Sanofi pays $50 million for Revolution Medicines’ SHP2 inhibitor
Wednesday, July 25, 2018 - 14:42
in Psychology & Sociology
The partners expect to begin clinical studies of the compound later this year
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via